Member Info for CHELSEA7

Cars, agree with you totally and yes it was an acquatance og RG that first got us FT coverage, perhaps it was even as far back as to the time when our first deal was close to happening.

Easy for me, my 100k buys top ups in the mid 7s were my last buys so not ducking and diving and would happily log into my P/F and not drown!!

Just focusing on that £19.2m M/Cap, our SCIB1 data from the monotherapy trial, forgetting everything else but the SCIB 1 Combo Trial even and it just doesn"t look right.. Very good timing this FT article, could well herald in the start of news releases we have dreamt of.

Must have been in 1945!!

Must have been in 1945!!

Oh well, pick up on that tomorrow. With that piece on Oncimmune too Samantha Pastons CV gets more impressive each passing day, and Inanaco given the recent update on SCIB 2 Trial under CRUK what timeline do you feel comfortable with to begin trial in? There are so many avenues of news (and deals to come). With three trials possibly running side by side in 2020. Bit like London Buses, certainly feels like it. Night guys.

Haven"t had a chance to read that PDF yet, definately haven"t seen it before. Lost me a bit, when you say.............

""This new platform has puzzled me.... is it a glycan mab platform or something else... I have found this""

Where did you find that??

I have never seen that PDF!!! Wondering how I missed that?

Just thinking about RG being out there in Philly, and reading the start of the FT article suggesting our price fall is party down to still waiting for IND for SCIB1 trial in U.S.A. Hard to imagine we werent in talks with Ichor and the FDA about that issue alone. All contacts including Keith Flaherty were down to RG and almost certainly many more that we don"t know about. Just going back to that time we were speculating what was meant by "seeking further validation"., looking back on that I just wonder if they were talking about further trial data??

You also mentioned China, and my memory banks are not so clever ATM, but didn"t RG go there the first time to support his wife on a book launch?? Really not sure where I heard that, but it has stuck in my mind. Anyway will be catching up on that PDF, Maybe i"ve just forgotten I have read it, lol.

Really don"t know if Cliff Holloway was there, and funny you mentioned China, just been having a conversation about that with a share holder. Did we ever get the Patentapproved there?

Amazing, it is hard to even get one post to send, now it sends two, lol.

Well lets hope it is. Our M/Cap stands at £19.2m today.................how many times have we been valued at £40m+?? A return to that would be a price of 10.5p and have we ever been better positioned to carry that price tag??

There are some very positive vibes coming out of Scancell, a lot of excitement over returning to trials and taking the pipeline into trials too. Very pleased also that RG was out in Philly, for a few reasons, least of all to know Team Scancell are very busy here.

Well lets hope it is. Our M/Cap stands at £19.2m today.................how many times have we been valued at £40m+?? A return to that would be a price of 10.5p and have we ever been better positioned to carry that price tag??

There are some very positive vibes coming out of Scancell, a lot of excitement over returning to trials and taking the pipeline into trials too. Very pleased also that RG was out in Philly, for a few reasons, least of all to know Team Scancell are very busy here.

Thanks deadly, sorry to have made a deal of that, but I spent 20+years in marketing and I am sure the public PR will go up a few gears now the trial is about to begin. We just don"t see the PR that goes on to the Industry as a whole, hence the article in the FT today, and it really wouldn"t surprise me that we get news next week as well. I am pretty sure the last time we got an FT article we rose 20% the week after, and sticking with the MMs are having a hard time getting any real quantity of shares, with news of SCIB 1 trial as well we will IMHO be on the way back up to double figures (dependant on other news too).

Just imagine what a bit of sustained demand for shares could do, so looking forward to next week, as ever ATB

Anybody heard previously of"" Maggy Centers""? On Sky News through the morning they have put the spotlight on an organisation run by Cancer Nurses where patients/families can go to for help in coping, personal skills, company and just being in an envirement away from home which for many is just a constant reminder of the awesome challenges many face. Apparantly there are 24 such centers open across Europe, I will do some research on them later, but my biggest surprise is I have never heard of them, and that is after being pretty well up to date with help offered by CRUK, McMillens and Hospices in general.

I have often said that the kindness, love and support, particularly amongst other patients is something rather special, probably the only place where you are stripped bare, no pretentions, no judgements and an incredibly strong bond with all and sundry and for many it just reminds you how lucky you are, regardless of your own personal diagnosis and prognosis.

Will post up some links this weekend , just in the hope that one person feels it can help them, a relative, or friend. It is like so many things in life, there is life changing help available if only people know about it. Particularly like the sound of this one although with just 24 centers, how many people can it reach?

Catch yer later..................and looking forward to seeing the FT today to see if that article is in it. I seem to remember on the last occasion we had a write up there we saw a very significant rise afterwards.

Glad to hear that TF. Just seems to me that if it wasn"t for this BB often many people wouldn"t hear abot events, presentations and conferences that we are taking place in, or list our collaborators who are.

Nobody is saying that on the first day of the conference we will get game changing news, the important issue is that we are there. Once again, and thanks to the FT we have got an outstanding piece on our potential, I trust that will be in the weekend pages, and how good for Samantha Paston to see her previous employers Oncimmune right there too. In fact it is an honour we are listed among them and AVO, with a M/Cap of some £92m compared to our £20m.

So it is just the odd comments suggesting we/I promise huge news during the conference, as I have said and always say lets hope the seeds that are sewn blossom and considering the fact we are nearing the SCIB1 trial, agreement with BioNTech to be renegotiated and amongst our other collaborators is very important.

It just feels when there is a big positive, negativity finds a place. Really, what more can we expect and that piece from FT is very good news and sets us up nicely for what many of us see as a very important June with the trial starting alone.

Have a good weekend too, no problem, very well done to Deadly for finding the article too. Just perhaps TF if it was you finding out such good information you might just feel a bit deflated hearing about our poor PR. PR has and will click into gear now, as it has for a long time and you can judge that by how many leaders in the Oncology world think highly of us.

PR is not just there to cause a spike for traders but to widen our name so we are rerated accordingly in the future. ATB

Lets be very proud we were one of three companies mentioned. Oncimmune very well known to us, and of cours Samantha Pastons former employess, Advanced Oncotherapy, with a M/Cap of some £92m, despite being savaged by Tom Winnifrith and opening soon their Proton Centre in Harley Street, a mere stones throw the UCLH new buiding dedicated to same, as they rightly point up their shares have recovered some 200% in the last two years.

These are the names we are being written about with, we should be very proud, and it will only get better. Lets ave the PR to those who have helped us get this far such. Well past mine, goodnight

Deadly, I have to disagree with that. Do you remember a guy called richardgdawson, who criticised us for making too big a deal of conferences and exhibitions, expecting instant results etc etc. I took his point and diagreed with him too, because we weren"t expecting instant results just being able to explain our science and data sticks with the minds of all who attend,

Those comments from the FT were from Asco, seeds we had sewn years before and never becoming more relevant than they are now, Thats the reason we attend these conferences or don"t unless we have new data to show them which please G-d next year will be in abundance.

The Philadelphia conference that RG attended was full of collaborators we havem business associates and the window to the world in Oncology, The results will be seen and relationships will be made for future days.

On our return, like now, our PR will add to the comments made, we have made some inpression to get the article printed, with all due respect Panama 7 has been like a needle stuck in a rcord with his disparaging comments. PR is a two way thing, one to PIs aimed at spikes and most importantly to the industry as a whole. I am sure none of us are not aware that that PR has been very succesful in helping us to become a very well known company known in the right circles.

It doesn"t help to read TFs comments like ""still no news" from events we are not expecting immediate comments from. It ia a combination of many factors that have got us to where we are, lets not forget that, seeds that were seen many years ago are flowering now. No I don"t agree with his repetitive criticisms at all, they take away from the progress we are making, which John Glencross confirms amongst many othere, false expectation is our worst eneny.

Inanaco, enjoyed our chat very much, seven recs already, just a sign it is not just me who has been looking forward to seeing you back.

Lets temper news about BioNTech, we last thing we want to do is be rght on a couple and wrong on two more, news of SCIB1 trial is firmly in our hands, that is our immediate focus, not dodgy panic on the funding front. Each piece of good news will have a knonk on effect in that regard.

A mix bag of news from Asco and in linewithmy own oncologist who cancelled two CarT Trials at the expense of diagnosis and matching treatments, it is there the biggest improvements can be clearly seen, established nd when the next wave ofnew treatments hits us, better survival statistics will be seen too.

Got another appt next Wednesday, couldn"t attend today, so giving a lot of though to being admitted to u.c.l.h, i really should be there and allow them to get new data too. Swapping my bed, freedom and telly for a ward for two weeks does little to excite me, but just perhaps needs must, and only we know when.

Newbies I hope you are reading these pages, judging for yourself good entry points, i gurantee you one thing the vast majority of us would liketo dive in at these levels in retrospect, judge for yourelf wht to believe and we hope to hve you with us on this very exciting journey. You migh notice our vlidations afre far reaching across the costs, ns seems like we will have a write up in the FT over the weekend as to our standing,not British Bulls but a much higher echelon.

Wish you all a good weekend, as Bobbust has said ""Is there another share on AIM like this"", willleave that up to you. Be lucky.

Second that chester, been a good week, have made a point of being in contact with the old LTH who we shared a lot with over abe an eight year period.

Relationships haven"t died, far from it, we all just can£t believe the years have passed us how quickly as they have.

To the man/women we are very excited a s to where we arem progress is clear and perhaps next week we shall find out the latest.. No point in conlinually admonoshing the share price, just a great entry price for newbies or averaging dowm, always good to see the F running an article presumably for the weekend........................every little hopes, and just anothe reinforcement we are noticed not by British BULLS but by those most respected in the Oncology World. as has been the case for so long. A few sell s by the close each a max of £500 of shares, MMs still struggling to get those shares, we will move when we least expect it, and good lck to the vast majority who are hoping for that too.

Nice one inanaco.

Have a great weekend guys.

Buys 250k

Sells 48k

VWAP 5.18

14 Trades..................9 buys...............5 sells

+1.02%

Hmmm, interesting question. Perhaps it makes their platform work better.

I think we will see a big rise here on news that Ichor are no longer needed IMHO